Invention Grant
![Crystalline forms of 2-[3-[4-amino-3-(2-fluoro-4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4,4-dimethylpent-2-enenitrile](/docs/US/2023-06-06/US11667641B2/abs.jpg.600x600.jpg)
- Patent Title: Crystalline forms of 2-[3-[4-amino-3-(2-fluoro-4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4,4-dimethylpent-2-enenitrile
-
Application No.: US17143355Application Date: 2021-01-07
-
Publication No.: US11667641B2Publication Date: 2023-06-06
- Inventor: Pasit Phiasivongsa , Jiang Zhu , Kolbot By , Mohammad Reza Masjedizadeh
- Applicant: Principia Biopharma Inc.
- Applicant Address: US CA South San Francisco
- Assignee: Principia Biopharma Inc.
- Current Assignee: Principia Biopharma Inc.
- Current Assignee Address: US NJ Bridgewater
- Agency: McNeill Baur PLLC
- Main IPC: A61K31/519
- IPC: A61K31/519 ; C07D487/04
![Crystalline forms of 2-[3-[4-amino-3-(2-fluoro-4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4,4-dimethylpent-2-enenitrile](/abs-image/US/2023/06/06/US11667641B2/abs.jpg.150x150.jpg)
Abstract:
Crystalline forms of Compound (I):
are disclosed. Pharmaceutical compositions comprising the same, methods of inhibiting BTK using the same, and methods for making crystalline forms of Compound (I) are also disclosed.
are disclosed. Pharmaceutical compositions comprising the same, methods of inhibiting BTK using the same, and methods for making crystalline forms of Compound (I) are also disclosed.
Public/Granted literature
Information query
IPC分类:
